Performance analysis of NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW)
Annual Return
Over the past 3 years, NRSNW has had an average annual return of -28.89%, underperforming the benchmark SPY, which returned +22.45% annual.
Since Dec 9, 2021, NRSNW has had an average annual return of -36.49%, underperforming the benchmark SPY, which returned +12.87% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -58.77% | -27.34% | +463.52% | -51.51% | -82.38% | -9.51% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +18.86% | -45.00% | -4.30% | -0.05% | -63.16% | +79.01% | -58.77% | ||||||
| 2025 | -47.73% | -13.04% | +2.68% | +40.04% | +68.32% | +31.05% | -13.28% | +3.64% | -33.35% | -23.26% | +43.99% | -23.86% | -27.34% |
| 2024 | +156.14% | +40% | +50% | -41.63% | -38.81% | +37.37% | -27.21% | +13.33% | -11.71% | +18.37% | +35.65% | +82.56% | +463.52% |
| 2023 | +78.86% | +80.60% | -25.17% | -10.38% | -28.32% | -5.45% | +3.46% | -34.57% | -3.16% | -28.36% | +125.20% | -68.77% | -51.51% |
| 2022 | -23.42% | -30.00% | +22.94% | -25.27% | -35.83% | +76.57% | -43.56% | -13.19% | +18.07% | -25.47% | +34.27% | -45.47% | -82.38% |
| 2021 | -9.51% | -9.51% |
Drawdown analysis of NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW)
The maximum drawdown for the NRSNW was -93.65%, occurring on May 18, 2026. This drawdown has not yet recovered.
The current NRSNW drawdown is -88.54%.
Since Dec 9, 2021 NRSNW has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.65% | Mar 21, 2022 | 1042 | May 18, 2026 | Ongoing | Ongoing | Ongoing |
| -77.35% | Dec 13, 2021 | 65 | Mar 17, 2022 | 2 | Mar 21, 2022 | 67 |
| -5.94% | Dec 9, 2021 | 1 | Dec 10, 2021 | 1 | Dec 13, 2021 | 2 |